• A Textbook Case of Human T-lymphotropic Virus-1 (HTLV-1)-Induced Adult T-cell Leukemia Treated With Cyclophosphamide, Hydroxydaunorubicin, Oncovin, and Prednisone/Prednisolone (CHOP)
• Advances in the treatment of human T-cell lymphotropic virus type-I associated myelopathy
• An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits
• Anti-HTLV-1 immunity combined with proviral load as predictive biomarkers for adult T-cell leukemia-lymphoma
• Association between Brain White Matter Lesions and Disease Activity in HAM/TSP Patients
• Blood-borne viruses and neurological manifestations: An overview
• Cannabinoid receptors as new targets for HTLV-1 associated myelopathy (HAM/TSP) treatment
• Cognitive deficits in HTLV-1 patients
• Complete Rescue of HTLV-1_p12KO Infectivity by Depletion of Monocytes Together with NK and CD8⁺ T Cells
• Comprehensive Insight into the Functional Roles of NK and NKT Cells in HTLV-1-Associated Diseases and Asymptomatic Carriers
• Correction: Performance of the national institute of infectious diseases disability scale in HTLV-1-associated myelopathy/tropical spastic paraparesis
• Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals
• Detection of HTLV-1 proviral DNA in cell-free DNA: Potential for non-invasive monitoring of Adult T cell leukaemia/lymphoma using liquid biopsy?
• Determination of molecular epidemiologic pattern of human T-lymphotropic virus type 1 (HTLV-1) in Alborz province, Iran
• Differential modulation of IL-4, IL-10, IL-17, and IFN-γ production mediated by IgG from Human T-lymphotropic virus-1 (HTLV-1) infected patients on healthy peripheral T (CD4+, CD8+, and γδ) and B cells
• Effects of HTLV-1 on leukocyte trafficking and migration in ACs compared to healthy individuals
• Epidemiological and clinical profile of HTLV-1 patients: a closer look at a reference center in Bahia, Brazil
• Higher expression of BRCA1, and CHUK and lower expression of NFKBIA, ESR1, PIK3R1, and PPARG in HAM/TSP compared to ATLL, a diverse pathological consequence
• HLA-A*24 Increases the Risk of HTLV-1-Associated Myelopathy despite Reducing HTLV-1 Proviral Load
• How do socioeconomic determinants of health affect the likelihood of living with HTLV-1 globally? A systematic review with meta-analysis
• HTLV in Sweden
• HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP): Case based discussion of risk factors, clinical, and therapeutic considerations
• HTLV-1 induces an inflammatory CD4+CD8+ T cell population in HTLV-1-associated myelopathy
• HTLV-1 p12 modulates the levels of prion protein (PrP^C) in CD4⁺ T cells
• HTLV-1 Proviral Load Absolute RT-qPCR Development for Assessing on Clinical Outcomes in HAM/TSP Patients
• HTLV-1 Proviral Load in Vaginal Fluid Correlates with Levels in Peripheral Blood Mononuclear Cells
• HTLV-1 reverse transcriptase homology model provides structural basis for sensitivity to existing nucleoside/nucleotide reverse transcriptase inhibitors
• HTLV-1 vaccination Landscape: Current developments and challenges
• HTLV-1-associated myelopathy in Spain
• HTLV-1-associated myelopathy/tropical spastic paraplegia with sporadic late-onset nemaline myopathy: a case report
• Human T-cell leukemia virus type 1 is associated with dysthyroidism in the French Amazon
• Human T-cell lymphotropic virus type 1 (HTLV-1) grip on T-cells: investigating the viral tapestry of activation
• Identification of miRnas with possible prognostic roles for HAM/TSP
• IL-10 predicts incident neuroinflammatory disease and proviral load dynamics in a large Brazilian cohort of people living with human T-lymphotropic virus type 1
• Iliopsoas Muscle Weakness as a Key Diagnostic Marker in HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
• Imbalanced IL10/TGF-beta production by regulatory T-lymphocytes in patients with HTLV-1-associated myelopathy/ tropical spastic paraparesis
• Infective dermatitis associated with human T-cell lymphotropic virus type-1, an underdiagnosed disease
• Investigating the effect of <em>MAP2K1</em> gene (MEK1) in MAPK pathway in the induction of adult T-cell leukemia/lymphoma (ATLL)
• Lived Experience of Human T-cell Leukemia Virus type-1 -Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): A Phenomenology Study
• Mechanisms of Innate Immune Sensing of HTLV-1 and Viral Immune Evasion
• Mogamulizumab for Treatment of HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis: A Single-Center US-Based Series
• Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy
• Mycophenolate mofetil for the long-term treatment of HTLV-1 associated myelopathy: A case report
• National Questionnaire Survey on the Actual Use and Content Evaluation of the human T-cell leukemia virus type I (HTLV-1) -associated Myelopathy (HAM) Practice Guidelines 2019
• Natural Selection Signatures in the Hondo and Ryukyu Japanese Subpopulations
• Neurological aspects of HTLV-1 infection: symptoms in apparently asymptomatic carriers
• Non-cancerous complications in HTLV-1 carriers
• Nonpharmacological interventions and outcomes in the management of complications of human T-cell lymphotropic virus type 1-related myelopathy/tropical spastic paraparesis: A systematic review
• Novel insights into human T-lymphotropic virus type-1 (HTLV-1) pathogenesis-host interactions in the manifestation of HTLV-1-associated myelopathy/tropical spastic paraparesis
• Patient research priority setting partnership in human T-cell lymphotropic virus type I
• Pentraxin 3, a serum biomarker in human T-cell lymphotropic virus type-1-associated myelopathy patients and asymptomatic carriers
• Performance of the National Institute of Infectious Diseases disability scale in HTLV-1-associated myelopathy/tropical spastic paraparesis
• Physiotherapy Methods Applied in the Prevention of Functional Loss Associated with Human T-Lymphotropic Virus 1 Infection: An Overview
• Putative role of HLA polymorphism among a Brazilian HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) population
• Retroviral b-Zip protein (HBZ) contributes to the release of soluble and exosomal immune checkpoint molecules in the context of neuroinflammation
• Role of Interleukin-17 cytokine family in human T-cell lymphotropic virus type 1 (HTLV-1) infection and associated diseases
• T helper type 9 cell response and its role in the neurological clinic of patients with Human T-lymphotropic virus 1
• Targeted immunotherapy for HTLV-1-associated myelopathy: a step in the right direction
• Teaching Video NeuroImage: HTLV-1-Associated Myelopathy With Downbeat Nystagmus
• The mirror like expression of genes involved in the FOXO signaling pathway could be effective in the pathogenesis of human lymphotropic virus type 1 (HTLV-1) through disruption of the downstream pathways
• The tyrosine kinase KDR is essential for the survival of HTLV-1-infected T cells by stabilizing the Tax oncoprotein
• Tropical spastic paraparesis
• Viral Immune signatures from cerebrospinal fluid extracellular vesicles and particles in HAM and other chronic neurological diseases